Jbs N.V. · JBS · FY2025 Q4 · Calendar Q2 2026

JBS posts record revenue while expanding beyond the US beef cycle

The supplied analysis supports a constructive operating thesis based on resilient multi-protein demand, geographic diversification, value-added products, and planned capacity expansion. The main counterweights are US cattle-cycle volatility, input costs, working-capital demands, and execution risk on the larger capex program.

Reported After market closeNYSEConsumer Defensive $25.66B market cap
90quality score

Earnings scorecard

Reported versus consensus
Reported EPS $0.20 Consensus $0.20
EPS surprise -2.2% Reported versus consensus
Reported revenue $21.61B Consensus $21.66B
Revenue surprise -0.2% Reported versus consensus

Market reaction

event-close to next-session close
Stock move -3.8% Event window
SPY move +0.6% Same window
Abnormal move -4.4% Stock minus SPY
Volume 2.6× Versus trailing sessions
Subsequent drift -17.0% Up to 20 sessions
JBSSPY benchmark

Ask FN2 about JBS FY2025 Q4

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

JBS is increasing its expansion focus: management outlined $1.4 billion of 2026 capex, a new table-egg business, higher Seara and Tasmania capacity, and continued investment in value-added brands. Guidance sentiment was maintained, while the supplied analysis flags ongoing US beef-cycle and cost risks.

Guidance delta

Management's guidance sentiment was maintained; no quantified guidance change was supplied.

Key takeaways

  • Management reported record 2025 revenue and a 7.9% full-year EBITDA margin despite a challenging US beef cycle.
  • The company emphasized geographic diversification, value-added brands, and a strong balance sheet as supports for the business.
  • JBS plans $1.4 billion of 2026 capital expenditure, including expansion projects and new egg facilities.

Management priorities

  • Execute the 2026 capex program across Pilgrim's, Paraguay, Oman, and Texas.
  • Scale Seara capacity and expand salmon production in Tasmania.
  • Build the US and Brazil egg businesses and grow value-added brands.
  • Maintain dividend payouts and evaluate share repurchases based on cash flow.

Follow JBS with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
JBS REVENUE earnings history estimate and actual scatter chart 5 reported fiscal quarters and 4 future estimate-only quarters. Q2 '25 estimate $22B Q2 '25 actual $22B, miss Q3 '25 estimate $22B Q3 '25 actual $23B, beat Q4 '25 estimate $120B Q4 '25 actual $23B, miss Q1 '26 estimate $22B Q1 '26 actual $22B, miss Q2 '26 estimate $23B Q2 '26 actual $24B, beat Q3 '26 estimate $122B Q4 '26 estimate $125B Q1 '27 estimate $114B Q2 '27 estimate $124B

Analyst Consensus ?

ConsensusBuy4 ratings
Bullish4100.0%
Neutral00.0%
Bearish00.0%

Analyst 52W Price Targets

$11.6Current
$17Low
$18.33Average
$20High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 28, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
UBS Buy BuyMaintainAug 24, 2026
Stephens & Co. Overweight OverweightMaintainAug 17, 2026
JP Morgan Overweight OverweightMaintainAug 12, 2026
Barclays Overweight OverweightMaintainJul 16, 2026

Named analyst price targets

Upside is calculated against the persisted current price $11.6. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
UBSAnalyst unavailable$17.5$13.82 +50.9%Aug 24, 2026
StephensPoorah Sharma$17$13.65 +46.6%Aug 17, 2026
BarclaysAnalyst unavailable$20$12.1 +72.4%Jul 16, 2026
UBSAnalyst unavailable$17$12.52 +46.6%May 19, 2026
BarclaysAnalyst unavailable$23$17.03 +98.3%Mar 27, 2026
See 4 more

Track every rating change on JBS the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

JBS NV is a food company that engages in the sale of beef, pork, lamb meat and poultry products. It offers its products to supermarkets, club stores, other retail distributors, and foodservice companies. The company was founded on October 9, 2019 and is headquartered in Amstelveen, the Netherlands.

Historical context

All JBS earnings

Consumer Defensive peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the JBS recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-13T04:18:24.985996+00:00
  2. FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
  3. Polygon adjusted daily market bars · 2026-09-28T18:50:57.407309+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-28T18:50:57.404397+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-09-28. For educational purposes only; not investment advice.